Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOFACITINIB Cause Therapeutic response unexpected? 1,384 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,384 reports of Therapeutic response unexpected have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.9% of all adverse event reports for TOFACITINIB.

1,384
Reports of Therapeutic response unexpected with TOFACITINIB
0.9%
of all TOFACITINIB reports
6
Deaths
95
Hospitalizations

How Dangerous Is Therapeutic response unexpected From TOFACITINIB?

Of the 1,384 reports, 6 (0.4%) resulted in death, 95 (6.9%) required hospitalization, and 3 (0.2%) were considered life-threatening.

Is Therapeutic response unexpected Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,384 reports have been filed with the FAERS database.

What Other Side Effects Does TOFACITINIB Cause?

Drug ineffective (30,382) Pain (21,659) Condition aggravated (16,925) Arthralgia (15,640) Fatigue (13,551) Rheumatoid arthritis (12,277) Off label use (11,736) Headache (11,061) Joint swelling (10,686) Malaise (9,040)

What Other Drugs Cause Therapeutic response unexpected?

SODIUM OXYBATE (1,710) CETIRIZINE (1,690) DICLOFENAC (1,583) NAPROXEN (1,393) DALFAMPRIDINE (1,263) DUPILUMAB (1,207) MINOXIDIL (1,043) ACETAMINOPHEN (985) PREGABALIN (972) ADALIMUMAB (772)

Which TOFACITINIB Alternatives Have Lower Therapeutic response unexpected Risk?

TOFACITINIB vs TOFERSEN TOFACITINIB vs TOLNAFTATE TOFACITINIB vs TOLODODEKIN ALFA TOFACITINIB vs TOLTERODINE TOFACITINIB vs TOLVAPTAN

Related Pages

TOFACITINIB Full Profile All Therapeutic response unexpected Reports All Drugs Causing Therapeutic response unexpected TOFACITINIB Demographics